BioPractice - BioMedical

Thursday - 30th May 2013
02:00 PM EDT | 11:00 AM PDT

Thursday - 6th June 2013
01:00 PM EDT | 10:00 AM PDT

Friday - 21st June 2013
02:00 PM EDT | 11:00 AM PDT

Wednesday - 26th June 2013
10:00 AM EDT | 07:00 AM PDT

Friday - 28th June 2013
02:00 PM EDT | 11:00 AM PDT

Friday - 12th July 2013
02:00 PM EDT | 11:00 AM PDT


		European and Canadian Experience Providing Insights into DEVELOPING BIOSIMILAR OR SUBSEQUENT ENTRY BIOLOGICS The importance & impact of the EU RMP& US REMS to risk-benefit assessments The current status of biosimilar biologics : Part 1: An international perspective The current status of biosimilar biologics : Part 2: Practical considerations in international development through European lessons learned


		Enuropean and Canadian Experience Providing Insights into DEVELOPING BIOSIMILAR OR SUBSEQUENT ENTRY BIOLOGICS The importance & impact of the EU RMP& US REMS to risk-benefit assessments The current status of biosimilar biologics : Part 1: An international perspective The current status of biosimilar biologics : Part 2: Practical considerations in international development through European lessons learned

Content Disclaimer:
Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility
for the content of such links and websites.